Adverse drug reactions and trial-and-error dosing are avoidable when genotype is known at the point of prescription.
CPIC-aligned gene–drug interpretation
Pre-emptive dosing guidance at prescription
Interoperable results for EHR and pharmacy systems
Every call is evidence-linked and auditable.
A qualified reviewer signs off every result.
FHIR reports drop into your existing systems.
Outcome — Safer prescribing, fewer adverse events.
Anchor sites get early capability and a real say in the roadmap.